Hiroyuki Takahashi

7PUBLICATIONS
12CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMolecular targetsHaematologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 02, 2025
Chemokine Expression in Well-Differentiated Liposarcoma May Be Involved in the Tumorigenesis of Lymphoplasmacytic Lymphoma: A Case Study.

Kota Washimi, Rika Kasajima, Shinya Sato

|Jan 06, 2025
SMARCA4-deficient epithelioid sarcoma revealed by comprehensive genomic profiling, leading to a notable response by nivolumab treatment.

Mayumi Tokunaga, Hiroyuki Takahashi, Natsuki Hirose

|Dec 26, 2024
Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case Report.

Yuto Hibino, Rika Sakai, Hiroyuki Takahashi

|Dec 03, 2023
The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.

Soji Toda, Hiroyuki Iwasaki, Yoichiro Okubo

|May 27, 2022
Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantation.

Haruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki

|Feb 07, 2022
Successful treatment with brentuximab vedotine for a patient with very late relapse of limited stage classic Hodgkin lymphoma.

Jun Nukui, Hiroyuki Takahashi, Mayumi Tokunaga

Pageof 2

Frequent Collaborators

2 joint publications

Kota Washimi

1 joint publications

Haruka Teshigawara-Tanabe

1 joint publications

Maki Hagihara

1 joint publications

Takayoshi Tachibana